IL18 and Hepatic steatosis: In concordance with the IL-18 levels, both Balb/c and Nlrp1b1-transgenic mice showed reduced hepatic steatosis and reduced dyslipidemia when fed with the HFD than obese Wt C57BL/6 mice.